Evidence map›Paper›PMID 21870032›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2011

Anti-nociceptive and anti-inflammatory activities of (-)-α-bisabolol in rodents.

Nayrton Flávio Moura Rocha, Emiliano Ricardo Vasconcelos Rios, Alyne Mara Rodrigues Carvalho, Gilberto Santos Cerqueira, Amanda de Araújo Lopes, Luzia Kalyne Almeida Moreira Leal, Marília Leite Dias, Damião Pergentino de Sousa, Francisca Cléa Florenço de Sousa

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. A Fresh Look at Mouthwashes-What Is Inside and What Is It For?International journal of environmental research and public health · 2022
    Article
  14. Article
  15. GC-MS Analysis and Various In Vitro and In Vivo Pharmacological Potential ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. Article
  17. Article
  18. Analgesic Potential of Terpenes Derived fromPharmacological reviews · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nayrton Flávio Moura RochaUniversidade Federal do Ceará, Fortaleza, Brazil. nayrtonf@hotmail.com
Emiliano Ricardo Vasconcelos Rios
Alyne Mara Rodrigues Carvalho
Gilberto Santos Cerqueira
Amanda de Araújo Lopes
Luzia Kalyne Almeida Moreira Leal
Marília Leite Dias
Damião Pergentino de Sousa
Francisca Cléa Florenço de Sousa
Universidade Federal do Ceará · BRUniversidade Federal de Sergipe · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(-)-α-Bisabolol is an unsaturated, optically active sesquiterpene alcohol obtained by the direct distillation of essential oil from plants such as Vanillosmopsis erythropappa and Matricaria chamomilla. (-)-α-Bisabolol has generated considerable economic interest, as it possesses a delicate floral odour and has been shown to have antiseptic and gastroprotective activities. In this study, (-)-α-bisabolol was tested in standardised rodent models by gavage administration at doses of 100 and 200 mg/kg in the models of inflammation and 25 and 50 mg/kg in the models of nociception. In the inflammatory models of paw oedema induced by carrageenan and dextran, the mice treated with (-)-α-bisabolol showed smaller oedemas compared to animals treated only with the vehicle. (-)-α-Bisabolol was capable of reducing paw oedemas induced by 5-HT but not oedemas induced by histamine. (-)-α-Bisabolol demonstrated anti-nociceptive activity in the models of visceral nociception induced by acetic acid and in the second phase of the nociception test induced by the intraplantar administration of formalin. (-)-α-Bisabolol did not have any effect in a thermal nociception model using a hot plate but was able to diminish mechanical inflammatory hypernociception evoked by carrageenan. These findings suggest that the anti-nociceptive action of (-)-α-bisabolol is not linked to a central mechanism but instead is related to the inflammatory process. (-)-α-Bisabolol was able to decrease leukocyte migration, protein extravasations and the amount of TNF-α to the peritoneal cavity in response to carrageenan. Additionally, (-)-α-bisabolol reduced neutrophil degranulation in response to phorbol-myristate-acetate. We demonstrate, for the first time, the peripheral anti-inflammatory and anti-nociceptive activities of (-)-α-bisabolol.

Indexed as

AnalgesicsAnimalsAnti-Inflammatory AgentsDisease Models, AnimalDose-Response Relationship, DrugEdemaInflammationMaleMiceMonocyclic SesquiterpenesNeutrophilsPainRatsSesquiterpenesTetradecanoylphorbol AcetateAnalgesicsAnti-Inflammatory AgentsbisabololMonocyclic SesquiterpenesSesquiterpenesTetradecanoylphorbol Acetate

Identifiers

PMID21870032
OpenAlexW2124724850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.